Semprus BioSciences Corp. landed a $500,000 grant from the National Science Foundation.
The Cambridge, Mass.-based company, which develops vascular access devices, said it will use the NSF’s Phase II-B grant to help commercialize its Semprus Sustain Performance products.
Sustain Performance is a coating that reduces bacterial growth and thrombus formation on medical devices and lasts for greater than 90 days, according to the company. If successful, the substance could negate the necessity to coat many implanted medical devices with antimicrobial agents.
The NSF’s grant to Semprus is part of the foundation’s Small Business Innovation Research Program. It’s the third such grant the company has won since its 2007 founding. Semprus has also been the recipient of funding from the National Institutes of Health, the Dept. of Energy and the Dept. of Defense.